[HTML][HTML] Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast …
H Denys, CL Martinez-Mena, MT Martens… - Breast cancer research …, 2020 - Springer
Purpose The subcutaneous (SC) administration of trastuzumab is highly preferred by
patients. At home, administration of trastuzumab SC might further improve patient benefit …
patients. At home, administration of trastuzumab SC might further improve patient benefit …
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the …
I Vergote, E Van Nieuwenhuysen… - International Journal of …, 2022 - ijgc.bmj.com
Objective Because elderly patients with ovarian cancer are underrepresented in randomized
studies, this study aimed to expand our knowledge on the safety and effectiveness of …
studies, this study aimed to expand our knowledge on the safety and effectiveness of …
FRI0304 Glucocorticoid Dose Reduction in Patients with Low Disease Activity Using Tocilizumab: the Act-Alone Study
C Ribbens, J Vanhoof, M Maertens… - Annals of the …, 2014 - ard.bmj.com
Background EULAR recommendations for the management of systemic glucocorticoid (GC)
therapy in rheumatoid arthritis (RA) state that a reduction and even a discontinuation should …
therapy in rheumatoid arthritis (RA) state that a reduction and even a discontinuation should …